Software feature guide

Clinical decision support

Clinical decision support brings relevant medication, diagnosis, laboratory, interaction, guideline, or screening context into the review workflow while leaving the consultant pharmacist responsible for interpretation and action.

Cross-vendor evidence

What the reviewed public sources currently support

Follow a product to inspect its source list, evidence context, limitations, and review date. Vendor-stated capabilities are not independent verification.

Clinical decision support across reviewed consultant pharmacist software
ProductClinical supportPricing
TrioMRRStructured review context
The vendor describes structured categories and psychotropic considerations, but the reviewed pages do not establish medication screening, interaction checking, or evidence-linked clinical guidance.Limited public detail
Pricing is not publicly listed
Framework RxPRecommendation support described
Enhanced, quick, and proposed recommendations are publicized, but the reviewed page does not describe medication screening, interaction logic, laboratory guidance, or evidence-linked prompts.Limited public detail
Custom quote
ConsultRxMonographs, interaction identification, and alerts
The vendor describes drug monographs, interaction identification, and clinical alerts within the consulting workflow.Vendor stated
Pricing is not publicly listed
RCShealth.ioMedication and interaction work
Medication, interaction, intervention, and monitoring functions are listed, but the reviewed page does not define the clinical content, alert logic, or supporting data.Limited public detail
Pricing is not publicly listed
methodRxConfigurable clinical templates
More than 600 premade customizable templates are publicized, but medication screening, interaction logic, laboratory guidance, and evidence-linked prompts are not described.Limited public detail
Early-adopter pricing mentioned; amount not public
OpalCareNot publicly specified
The reviewed page describes MRR, MTM, and care-management workflow but does not define medication screening, clinical-content sources, or decision-support logic.Not publicly specified
Pricing is not publicly listed
Profiles360Broad clinical screening and guidance tools
The current page lists drug-drug, drug-disease, and drug-food screening, disease and laboratory tools, calculators, assessments, benchmarks, and stewardship guidance.Vendor stated
Current pricing is not public
RxPertiseNot publicly specified
The reviewed current pages do not define medication screening, clinical-content sources, or decision-support logic.Not publicly specified
Pricing is not publicly listed
DocStationNot publicly specified
The reviewed pricing page does not define medication screening, interaction checking, laboratory guidance, or evidence-linked prompts.Not publicly specified
From $129 per location/month

What this feature typically includes

  • Medication monographs, interaction checks, and clinical screening
  • Diagnosis, laboratory, allergy, and medication context
  • Configurable guidance, calculators, or evidence-linked prompts

Products use similar feature labels for materially different workflows. Treat the label as a starting point: ask to see the capability using a representative resident, facility, and reporting scenario.

Questions to ask in a demo

  • Which data drives each alert or suggestion, and how current is it?
  • Can pharmacists inspect the source, logic, and relevant patient facts?
  • How are false positives, overrides, updates, and any AI-generated suggestions reviewed and recorded?

How to interpret the comparison

“Not publicly specified” means the evidence reviewed for this guide did not identify a sufficiently clear public claim. It does not prove the product lacks the feature. Vendor-stated capabilities should be demonstrated, scoped, and confirmed in current documentation or the contract before a buying decision.